GSK (LON:GSK) Reaches New 1-Year High at $1,670.10

GSK plc (LON:GSKGet Free Report) shares hit a new 52-week high during mid-day trading on Tuesday . The company traded as high as GBX 1,670.10 ($20.94) and last traded at GBX 1,662.60 ($20.84), with a volume of 10027802 shares trading hands. The stock had previously closed at GBX 1,611.20 ($20.20).

Analysts Set New Price Targets

GSK has been the topic of several recent analyst reports. Shore Capital reiterated a “buy” rating on shares of GSK in a report on Wednesday, January 31st. Citigroup restated a “neutral” rating on shares of GSK in a report on Tuesday, November 28th. Barclays restated an “equal weight” rating and issued a GBX 1,575 ($19.74) price target on shares of GSK in a report on Monday, December 18th. Finally, Berenberg Bank restated a “buy” rating and issued a GBX 1,650 ($20.68) price target on shares of GSK in a report on Friday, November 24th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of GBX 1,608.33 ($20.16).

Read Our Latest Stock Analysis on GSK

GSK Price Performance

The company has a market cap of £67.31 billion, a PE ratio of 1,393.83, a price-to-earnings-growth ratio of 1.29 and a beta of 0.26. The business’s 50 day moving average price is GBX 1,510.66 and its 200-day moving average price is GBX 1,458.26. The company has a quick ratio of 0.73, a current ratio of 0.88 and a debt-to-equity ratio of 140.82.

GSK Increases Dividend

The company also recently disclosed a dividend, which will be paid on Thursday, April 11th. Stockholders of record on Thursday, February 22nd will be paid a dividend of GBX 16 ($0.20) per share. The ex-dividend date is Thursday, February 22nd. This represents a dividend yield of 1.04%. This is a positive change from GSK’s previous dividend of $14.00. GSK’s dividend payout ratio (DPR) is currently 5,333.33%.

Insider Activity

In other news, insider Julie Brown acquired 19,360 shares of the company’s stock in a transaction dated Thursday, February 1st. The shares were bought at an average price of GBX 1,583 ($19.84) per share, for a total transaction of £306,468.80 ($384,190.55). In related news, insider Urs Rohner purchased 478 shares of the firm’s stock in a transaction dated Wednesday, December 20th. The stock was acquired at an average price of GBX 1,450 ($18.18) per share, with a total value of £6,931 ($8,688.73). Also, insider Julie Brown purchased 19,360 shares of the firm’s stock in a transaction dated Thursday, February 1st. The shares were bought at an average cost of GBX 1,583 ($19.84) per share, with a total value of £306,468.80 ($384,190.55). Insiders own 2.24% of the company’s stock.

GSK Company Profile

(Get Free Report)

GSK plc, together with its subsidiaries, engages in the research, development and manufacture of vaccines and specialty medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare.

Featured Articles

Receive News & Ratings for GSK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GSK and related companies with MarketBeat.com's FREE daily email newsletter.